New hope for young sarcoma patients: trial tests aggressive drug combo
NCT ID NCT06239272
Summary
This study is testing a combination of chemotherapy drugs (ifosfamide, doxorubicin), a targeted drug (pazopanib), and sometimes a newer drug (selinexor) and radiation therapy for young patients (up to age 30) with rare soft tissue cancers. The goal is to see if this approach can better control the cancer and improve survival. Patients are grouped by risk level (low, intermediate, high) and receive treatments tailored to their specific situation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact
Contact
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
Contact
-
Lurie Children's Hospital of Chicago
RECRUITINGChicago, Illinois, 60611, United States
Contact
Contact
-
Our Lady of the Lake Children's Hospital
RECRUITINGBaton Rouge, Louisiana, 70809, United States
Contact
Contact
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Washington University Medical Center
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.